通过CDDO-Im激活NRF2,调节人类微质细胞中的炎症和自途径
Ching-Tung Chu1, Akira Uruno1, Takafumi Suzuki2
1Department of Biochemistry and Molecular Biology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, 980-8573, Japan.
Free radical biology & medicine
|November 22, 2025
概括
核因子红色素2相关因子2 (NRF2) 在微质中的激活减少阿尔茨海默氏症.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 阿尔茨海默病 (AD) 病理包括粉样β斑块,神经纤维状,氧化应激和神经炎症.
- 微质,大脑的免疫细胞,对于清除病态聚合物和受损的神经元至关重要.
- 核因素红色素2相关因子2 (NRF2) 是细胞防御抗氧化应激的关键调节者,在AD模型中显示出治疗潜力.
研究的目的:
- 为了确定核因素红色素2相关因子2 (NRF2) 的直接微质点.
- 研究NRF2激活在调节微质炎症和自的作用.
- 探索NRF2介导途径作为阿尔茨海默病的潜在治疗点.
主要方法:
- 使用的人类微质细胞 (HMC3) 用干扰素- (IFN-γ) 或粉样β (Aβ) 刺激.
- 使用CDDO-Im激活NRF2,并通过RNA测序和使用ChIP测序分析NRF2结合位点来分析基因表达.
- 评估了自标志物 (LC3-II/LC3-I比) 和分析了来自AD大脑的公共单细胞转录组数据.
主要成果:
- 激活NRF2显著抑制了HMC3细胞中的炎症.
- 确定了参与炎症 (例如IL6,CDK6) 和自 (例如TFE3,SQSTM1) 的直接NRF2位基因.
- CDDO-Im治疗增强了自,并证实了NRF2在AD微细胞内自调节中的作用.
结论:
- 揭示了与阿尔茨海默病相关的微质中的新型直接NRF2点基因.
- 证明了NRF2在抑制神经炎症和促进自的双重功能.
- 这些发现为阿尔茨海默病治疗提供了针对NRF2通路的新治疗策略.
相关概念视频
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K
Regulation of the Unfolded Protein Response
2.9K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
Receptor Downregulation in MVBs
2.7K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.7K
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K


